RecruitingPhase 4NCT07105111
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Sponsor: Neurocrine Biosciences
Bonita Springs, FL · Hialeah, FL · Miami, FL · +16 more sites